PRGO
Perrigo Company plc
Drug Manufacturers - Specialty & Generic
Market Cap$1.61B
5Y Perf.-78.6%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
PRGO vs PBH
Revenue, margins, valuation, and 5-year total return — side by side.
PBH
Prestige Consumer Healthcare Inc.
Medical - Distribution
Market Cap$2.58B
5Y Perf.+29.4%
PRGO vs PBH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | PRGO | PBH |
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Medical - Distribution |
| Market Cap | $1.61B | $2.58B |
| Revenue (TTM) | $4.18B | $1.10B |
| Net Income (TTM) | $-1.82B | $187M |
| Gross Margin | 34.2% | 56.4% |
| Operating Margin | -4.1% | 29.2% |
| Forward P/E | 5.6x | 12.0x |
| Total Debt | $3.97B | $1.04B |
| Cash & Equiv. | $532M | $98M |
PRGO vs PBH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
PRGO
PBH
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Perrigo Company plc (PRGO) | 100 | 21.4 | -78.6% |
| Prestige Consumer H… (PBH) | 100 | 129.4 | +29.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PRGO vs PBH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PBH leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
PRGO
Perrigo Company plc
The Value Play
PRGO is the clearest fit if your priority is value and dividends.
- Lower P/E (5.6x vs 12.0x)
- 9.8% yield; 10-year raise streak; the other pay no meaningful dividend
Best for: value and dividends
PBH
Prestige Consumer Healthcare Inc.
The Income Pick
PBH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.53
- Rev growth 1.1%, EPS growth 2.9%, 3Y rev CAGR 1.5%
- -3.7% 10Y total return vs PRGO's -77.7%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PBH | 1.1% revenue growth vs PRGO's -2.8% |
| Value | PRGO | Lower P/E (5.6x vs 12.0x) |
| Quality / Margins | PBH | 16.9% margin vs PRGO's -43.5% |
| Stability / Safety | PBH | Beta 0.53 vs PRGO's 1.18, lower leverage |
| Dividends | PRGO | 9.8% yield; 10-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | PBH | -32.9% vs PRGO's -51.2% |
| Efficiency (ROA) | PBH | 5.3% ROA vs PRGO's -19.8%, ROIC 9.1% vs 3.7% |
PRGO vs PBH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
PRGO vs PBH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPBHLAGGINGPRGO
PRGOPerrigo Company plc
1leads
PBHPrestige Consumer Hea…
4leads
6 Total Categories
CATEGORYLEADERvs PRGOMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
PBH6/6
Valuation MetricsMultiples, price ratios, and targets
PRGO5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PBH9/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PBH6/6
Risk & VolatilityBeta, volatility, and downside exposure
PBH2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
PBH leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 3.8x PBH's $1.1B. PBH is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, PBH holds the edge at -2.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| RevenueTrailing 12 months | $4.2B | $1.1B |
| EBITDAEarnings before interest/tax | $58M | $353M |
| Net IncomeAfter-tax profit | -$1.8B | $187M |
| Free Cash FlowCash after capex | $108M | $267M |
| Gross MarginGross profit ÷ Revenue | +34.2% | +56.4% |
| Operating MarginEBIT ÷ Revenue | -4.1% | +29.2% |
| Net MarginNet income ÷ Revenue | -43.5% | +16.9% |
| FCF MarginFCF ÷ Revenue | +2.6% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -7.2% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -56.4% | -20.5% |
PBH leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
PRGO leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than PBH's 9.6x.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| Market CapShares × price | $1.6B | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $5.1B | $3.5B |
| Trailing P/EPrice ÷ TTM EPS | -1.14x | 12.72x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.56x | 12.02x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.40x |
| EV / EBITDAEnterprise value multiple | 7.42x | 9.62x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 2.27x |
| Price / BookPrice ÷ Book value/share | 0.55x | 1.49x |
| Price / FCFMarket cap ÷ FCF | 11.12x | 10.62x |
PRGO leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
PBH leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
PBH delivers a 10.2% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-51 for PRGO. PBH carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), PBH scores 8/9 vs PRGO's 4/9, reflecting strong financial health.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| ROE (TTM)Return on equity | -50.7% | +10.2% |
| ROA (TTM)Return on assets | -19.8% | +5.3% |
| ROICReturn on invested capital | +3.7% | +9.1% |
| ROCEReturn on capital employed | +4.3% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 8 |
| Debt / EquityFinancial leverage | 1.35x | 0.57x |
| Net DebtTotal debt minus cash | $3.4B | $946M |
| Cash & Equiv.Liquid assets | $532M | $98M |
| Total DebtShort + long-term debt | $4.0B | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | -7.20x | 7.40x |
PBH leads this category, winning 9 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PBH leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PBH five years ago would be worth $11,842 today (with dividends reinvested), compared to $3,986 for PRGO. Over the past 12 months, PBH leads with a -32.9% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors PBH at -2.8% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| YTD ReturnYear-to-date | -13.5% | -10.8% |
| 1-Year ReturnPast 12 months | -51.2% | -32.9% |
| 3-Year ReturnCumulative with dividends | -58.1% | -8.3% |
| 5-Year ReturnCumulative with dividends | -60.1% | +18.4% |
| 10-Year ReturnCumulative with dividends | -77.7% | -3.7% |
| CAGR (3Y)Annualised 3-year return | -25.2% | -2.8% |
PBH leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
PBH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PBH is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PBH currently trades 61.1% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.18x | 0.53x |
| 52-Week HighHighest price in past year | $28.44 | $89.37 |
| 52-Week LowLowest price in past year | $9.23 | $51.24 |
| % of 52W HighCurrent price vs 52-week peak | +41.2% | +61.1% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 36.4 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 478K |
PBH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates PRGO as "Hold" and PBH as "Buy". Consensus price targets imply 70.6% upside for PRGO (target: $20) vs 20.9% for PBH (target: $66). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.
| Metric | PRGOPerrigo Company p… | PBHPrestige Consumer… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $20.00 | $66.00 |
| # AnalystsCovering analysts | 36 | 17 |
| Dividend YieldAnnual dividend ÷ price | +9.8% | — |
| Dividend StreakConsecutive years of raises | 10 | — |
| Dividend / ShareAnnual DPS | $1.15 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
PBH leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 1 (Valuation Metrics).
Best OverallPrestige Consumer Healthcar… (PBH)Leads 4 of 6 categories
Loading custom metrics...
PRGO vs PBH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PRGO or PBH a better buy right now?
For growth investors, Prestige Consumer Healthcare Inc.
(PBH) is the stronger pick with 1. 1% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 7x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PRGO or PBH?
On forward P/E, Perrigo Company plc is actually cheaper at 5.
6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PRGO or PBH?
Over the past 5 years, Prestige Consumer Healthcare Inc.
(PBH) delivered a total return of +18. 4%, compared to -60. 1% for Perrigo Company plc (PRGO). Over 10 years, the gap is even starker: PBH returned -3. 7% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PRGO or PBH?
By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.
(PBH) is the lower-risk stock at 0. 53β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 121% more volatile than PBH relative to the S&P 500. On balance sheet safety, Prestige Consumer Healthcare Inc. (PBH) carries a lower debt/equity ratio of 57% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — PRGO or PBH?
By revenue growth (latest reported year), Prestige Consumer Healthcare Inc.
(PBH) is pulling ahead at 1. 1% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Prestige Consumer Healthcare Inc. grew EPS 2. 9% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PRGO or PBH?
Prestige Consumer Healthcare Inc.
(PBH) is the more profitable company, earning 18. 9% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 8. 1% for PRGO. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PRGO or PBH more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
6x forward P/E versus 12. 0x for Prestige Consumer Healthcare Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 70. 6% to $20. 00.
08Which pays a better dividend — PRGO or PBH?
In this comparison, PRGO (9.
8% yield) pays a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.
09Is PRGO or PBH better for a retirement portfolio?
For long-horizon retirement investors, Prestige Consumer Healthcare Inc.
(PBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Both have compounded well over 10 years (PBH: -3. 7%, PRGO: -77. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PRGO and PBH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PRGO is a small-cap income-oriented stock; PBH is a small-cap deep-value stock. PRGO pays a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(PRGO: -7.2% · PBH: -2.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.